Leidos Holdings, Inc. - LDOS STOCK NEWS

The Leidos Partnership for Defense Health (LPDH) announced the successful deployment of the MHS GENESIS electronic health record system to 15,000 clinicians across 14 Military Treatment Facility Commands in five states. This marks the largest double Wave deployment to date, expanding the system's operational capacity to 1,360 locations with over 92,000 active users. The project remains on schedule and within budget, with nine additional deployments planned through the end of 2023, aiming for full implementation by year-end.

Leidos (NYSE: LDOS) has secured a prime contract valued at $84 million from the U.S. Navy's NAVWAR to enhance undersea warfare systems. This task order spans one year with four additional option years. Operations will be conducted in Virginia and Japan. The contract involves providing operations and maintenance teams for the USNS Tactical Auxiliary General Ocean Surveillance vessels and engineering support for the Surveillance Towed Array Sensor System fleet.

Leidos (NYSE: LDOS) will participate in the J.P. Morgan 2022 Industrials Conference on March 17, 2022, at 1:20 p.m. ET in New York City. CEO Roger Krone will present, and a live audio webcast will be accessible on the Leidos Investor Relations website. A replay will be available for 30 days post-event. Leidos, a leading science and technology company headquartered in Reston, Virginia, reported $13.7 billion in revenues for the fiscal year ending December 31, 2021.

Leidos (NYSE:LDOS) secured a prime contract worth up to $545 million from the National Institute of Allergy and Infectious Diseases (NIAID) on March 9, 2022. This seven-year contract will enhance biomedical preclinical and development capabilities. Services include chemistry manufacturing, bioinformatics, and analytics. Leidos has supported U.S. biomedical research for over two decades, managing large contracts related to various diseases. The company reported $13.7 billion in revenue for fiscal 2021, underscoring its strong market presence.

Clearsense has announced a strategic partnership with Leidos (NYSE: LDOS) to enhance healthcare data management. The collaboration aims to provide a comprehensive managed services suite that delivers measurable ROI for healthcare organizations. This partnership builds on a previous successful project that saved a healthcare system around $20 million. Clearsense's innovative technology will streamline data processes, significantly reducing costs while improving patient care. This collaboration was highlighted at the ViVE 2022 event in Miami from March 6-9, 2022.

Leidos (NYSE: LDOS) has appointed retired Major General John George as its Army Strategic Account Executive. This role aims to enhance relationships with the United States Army and foster organic growth within the company. General George, with 33 years of experience in the Army, previously led the Combat Capabilities Development Command, overseeing a $13 billion modernization budget. His extensive background in military operations and technology development is expected to strengthen Leidos' market position and support its mission-critical initiatives.

Leidos (NYSE:LDOS) has appointed Maureen Waterston as the new Chief Human Resources Officer (CHRO), effective March 1, 2022. Waterston will enhance the human capital strategy for Leidos' 43,000-employee workforce. She previously served as CHRO at Pratt & Whitney and has extensive HR experience in global roles at United Technologies Corporation and Otis Elevator. Leidos reported approximately $13.7 billion in annual revenues for the fiscal year ending December 31, 2021, and operates in defense, intelligence, civil, and health markets.

Leidos has secured an $11.5 billion contract from the Defense Information Systems Agency for the Defense Enclave Services (DES) initiative. The contract spans four years, with options for three additional two-year periods. Leidos aims to enhance mission capabilities and user experience through a unified network architecture. CEO Roger Krone praised the award, emphasizing the company’s commitment to delivering critical support to military efforts. The firm reported revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.